Navigation Links
Blood clotting protein linked to rheumatoid arthritis
Date:11/16/2007

CINCINNATI Researchers at Cincinnati Childrens have issued the first study showing that a protein normally involved in blood clotting (fibrin), also plays an important role in the inflammatory response and development of rheumatoid arthritis. Inflammatory joint disease appears to be driven by the engagement of inflammatory cells with fibrin matrices through a specific integrin receptor, aMB2. Writing in the November issue of The Journal of Clinical Investigation, researchers suggest that therapies designed to interrupt the localized interaction of inflammatory cells and fibrin may help arthritis patients.

Our study establishes that fibrin is a powerful, although context-dependent, determinant of inflammatory joint disease, said Jay Degen, Ph.D., a researcher in Developmental Biology at Cincinnati Childrens and the studys lead author. These findings also suggest that pharmacologically interrupting the interaction of fibrin and aMB2 might be efficacious in the treatment of arthritic disease as well as many other inflammatory diseases, such as multiple sclerosis.

Affecting 2.1 million people in the United States, rheumatoid arthritis is a painful and debilitating disease involving chronic inflammation, tissue degeneration, loss of cartilage and bone and ultimately loss of joint mobility and function, according to the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Although the diseases precise cause is not fully known, activation of specific components in the bodys immune system seem to play a major role in its onset and early progression, according to researchers. Fibrin deposits are a prominent feature of arthritic joints and the protein appears to be a link between systems that control inflammation and bleeding within joints. Dr. Degen and his colleagues explained that in arthritic joints, the mesh-like matrices formed by fibrin to create blood clots may control local activity of inflammatory cells as well as support i
'/>"/>

Contact: Nick Miller
nicholas.miller@cchmc.org
513-803-6035
Cincinnati Children's Hospital Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. High blood pressure, low energy -- a recipe for heart failure
2. Right breakfast bread keeps blood sugar in check all day
3. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment
4. Folic acid lowers blood arsenic levels, according to Mailman School of Public Health study
5. Folic acid lowers blood arsenic levels in Bangladesh
6. Study reveals a key to blood vessel growth and possible drug target
7. Expecting an afternoon nap can reduce blood pressure
8. MIT: blood may help us think
9. Immune cells promote blood vessel formation in mouse endometriosis
10. Elevated nitric oxide in blood is key to high altitude function for Tibetans
11. Fine-tuning lasers to destroy blood-borne diseases like AIDS

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...producing some of the highest resolution images of...s have a deeper understanding how biomolecules man...d to a new treatment for kidney stones using biomo...v. 23 online edition of the journal Proceedings o...peptides interact with mineral surfaces by acceler...
(Date:11/23/2009)... new study by University of Alabama at Birmingham ... and co-existing medical conditions (co-morbidity)...ong African-Americans compared to Caucasians who a...ne Nov. 23 in Cancer , a journal of the American ...hough BMI and co-morbidity are independent predict...
(Date:11/23/2009)...w studies reveal in unprecedented detail how the r... new proteins and guide them toward their destinat...r dynamics flexible fitting (MDFF) to examine the ...ecular partners. , The first study, in Proceed...s the intimate signaling between the ribosome and ...
Breaking Biology News(10 mins):Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Catalyst Pharmaceutical Partners To Transfer To NASDAQ Capital Market 56090 1Catalyst Pharmaceutical Partners To Transfer To NASDAQ Capital Market 56090 2Liberty Screening Hires Top Sales Exec for Southeastern U S 56086 1Chindex International Announces September Investor Conferences Participation 56083 1Chindex International Announces September Investor Conferences Participation 56083 2
...ted to increase usability and adoption of SMS and ...cations, MENLO PARK, Calif., Sept. 10 Promptu Sy...ve voice-powered mobile,applications, unveiled tod...and highly accurate voice dictation system. Using ...ognition (CSSR(TM)) technology, the system convert...
... on the Market, Stantum,s SMK Series Will Let Vend...e Multi-Touch Applications, SAN DIEGO, Sept. 23 ... pioneer developer of multi-touch sensing,technolo...pment board based,on its patented PMatrix(TM) resi...ultaneously move an unlimited number of fingers, n...
... Stevens Institute of Technology has been awarded... to support research and development into biomass ...warded by the DOE to various higher-education inst...ts. In total, the DOE will invest up to $4.4 milli... into how non-food feedstocks can be transformed i...
Other Biology News:Promptu Unveils High Accuracy Voice-to-Text Dictation for Mobile Phones at CTIA 2Stantum Offering Demo, Evaluation & Development Board Based on Its Patented Resistive Multi-Touch Technology 2Stevens awarded $1M for advanced biofuels research 2
(Date:11/24/2009)...rk investment bank KTA Capital,s client Neuren Pha...l convertible note private placement with a U.S. i...rranged by KTA Capital as Neuren,s exclusive place... New York (PRWEB) November 23, 2009 -- The indepen...uot;KTA Capital") has announced that its clie...
(Date:11/24/2009).../PRNewswire-FirstCall/--deCODE,genetics,Inc.(Nasda...,theNasdaqStockMarketthattradinginthecompany,scomm...25-NSEwillbefiledwiththe,SecuritiesandExchangeComm...ingonNasdaq,unlessthecompanyfilesanappealtotheNasd...chanappeal,which,willstaythesuspensionanddelisting...
(Date:11/24/2009).../PRNewswire-FirstCall/--deCODE,genetics,Inc.(Nasda...tday"motionsbytheU.S.BankruptcyCourtfortheDistrict...ledavoluntarypetitionfor,reliefunderChapter11ofthe... , TheordersissuedbytheBankruptcyCourtallowth...apter11proceedings.Inparticular,the,companyreceive...
(Date:11/24/2009)...sia/--ShanghaiBiolaxyannouncedthe,ChineseStateFood...igationalnewdrugapplication(IND)foritsoralinsulinp...eatdiabetes.ThisIND,approvalallowsBiolaxytoinitiat...sordercharacteristicofhighbloodglucoseandpoor,meta...remicro-and,macro-vasculardiseases,lossofvision,ki...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2
...cus Therapeutics,(Nasdaq: FOLD ), a biopharmaceut...nistered pharmacological chaperones for the treatm...d quarter 2008 financial results after,the regular... results,announcement will be followed by a live c.... EDT., Interested participants and investors may...
...ultiple Markets, Including Industrial ... 31 PURE Bioscience (Nasdaq:,PURE) today announce...distribution of PURE,s silver dihydrogen citrate (...TM) brand., (Logo: http://www.newscom.com/cgi-bi...nal Inc, a Minneapolis based chemical manufacturer...
...utlook, MELVILLE, N.Y., July 31 Gentiva Health,S...ng provider of,comprehensive home health services,... by double-digit increases in Medicare revenues an..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...he quarter ended June 29, 2008 included:, -- A 13...
Other Biology Technology:Amicus Therapeutics Announces Second Quarter 2008 Results Release Date 2PURE Bioscience Announces DuraBan International as Distributor of SDC-Based Disinfectant 2PURE Bioscience Announces DuraBan International as Distributor of SDC-Based Disinfectant 3PURE Bioscience Announces DuraBan International as Distributor of SDC-Based Disinfectant 4Gentiva Reports Strong Second Quarter led by Home Health Segment 2Gentiva Reports Strong Second Quarter led by Home Health Segment 3Gentiva Reports Strong Second Quarter led by Home Health Segment 4Gentiva Reports Strong Second Quarter led by Home Health Segment 5Gentiva Reports Strong Second Quarter led by Home Health Segment 6Gentiva Reports Strong Second Quarter led by Home Health Segment 7Gentiva Reports Strong Second Quarter led by Home Health Segment 8Gentiva Reports Strong Second Quarter led by Home Health Segment 9Gentiva Reports Strong Second Quarter led by Home Health Segment 10Gentiva Reports Strong Second Quarter led by Home Health Segment 11Gentiva Reports Strong Second Quarter led by Home Health Segment 12
...mid-Based Deletion Machine is based on the simple,...developed by Goryshin and Reznikoff, and by York e...ns and inversions by intramolecular transposition ... plasmid vector. Although most researchers will be...
...romStreptomyces griseolusthat inhibits protein syn...tivity in eukaryote ribosomes. Reported to induce ...cytic leukemia cells, Jurkat cells, ventricular my...intracellular signals and immediate early gene ind...
VersArray Hybridization Chamber from Bio-Rad
...e-of-the-art separation system using the asymmetri...The Eclipse integrates easily with Wyatts multi-an...iDAWN Tristar, as well as the Optilab DSP. The com... distributions of the particles/molecules separate...
Biology Products: